Abstract
Although a prominent role for the brain in glucose homeostasis was proposed by scientists in the nineteenth century, research throughout most of the twentieth century focused on evidence that the function of pancreatic islets is both necessary and sufficient to explain glucose homeostasis, and that diabetes results from defects of insulin secretion, action or both. However, insulin-independent mechanisms, referred to as ‘glucose effectiveness’, account for roughly 50% of overall glucose disposal, and reduced glucose effectiveness also contributes importantly to diabetes pathogenesis. Although mechanisms underlying glucose effectiveness are poorly understood, growing evidence suggests that the brain can dynamically regulate this process in ways that improve or even normalize glycaemia in rodent models of diabetes. Here we present evidence of a brain-centred glucoregulatory system (BCGS) that can lower blood glucose levels via both insulin-dependent and -independent mechanisms, and propose a model in which complex and highly coordinated interactions between the BCGS and pancreatic islets promote normal glucose homeostasis. Because activation of either regulatory system can compensate for failure of the other, defects in both may be required for diabetes to develop. Consequently, therapies that target the BCGS in addition to conventional approaches based on enhancing insulin effects may have the potential to induce diabetes remission, whereas targeting just one typically does not.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ogden, C. L. et al. Prevalence of overweight and obesity in the United States, 1999–2004. J. Am. Med. Assoc. 295, 1549–1555 (2006)
Cowie, C. C. et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 29, 1263–1268 (2006)
Bernard, C. Leçons de Ohysiologie Experimentale Appliqués á là Medecine (Paris, J.-B. Baillière, 1854)
Biddinger, S. B. & Kahn, C. R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123–158 (2006)
Morton, G. J. et al. FGF19 action in the brain induces insulin-independent glucose lowering J. Clin. Invest. http://dx.doi.org/10.1172/JCI70710 (1 October 2013)Administration of a low dose of the hormone FGF19 directly into the brain of leptin-deficient ob/ob mice ameliorated glucose intolerance by rapidly, potently and selectively increasing glucose effectiveness.
Mingrone, G. et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 366, 1577–1585 (2012)
Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med. 366, 1567–1576 (2012)
Breen, D. M. et al. Jejunal nutrient sensing is required for duodenal–jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nature Med. 18, 950–955 (2012)
Jiao, J. et al. Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in zucker fa/fa rats. Diabetes 62, 1074–1083 (2013)
Cummings, D. E. & Flum, D. R. Gastrointestinal surgery as a treatment for diabetes. J. Am. Med. Assoc. 299, 341–343 (2008)
Kashyap, S. R. et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 36, 2175–2182 (2013)
Schwartz, M. W. & Porte, D., Jr Diabetes, obesity, and the brain. Science 307, 375–379 (2005)
Sandoval, D., Cota, D. & Seeley, R. J. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu. Rev. Physiol. 70, 513–535 (2008)
Elmquist, J. K., Coppari, R., Balthasar, N., Ichinose, M. & Lowell, B. B. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J. Comp. Neurol. 493, 63–71 (2005)
Obici, S., Zhang, B. B., Karkanias, G. & Rossetti, L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Med. 8, 1376–1382 (2002)
Lam, T. K., Gutierrez-Juarez, R., Pocai, A. & Rossetti, L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 309, 943–947 (2005)
Coppari, R. et al. The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63–72 (2005)
Morton, G. J. et al. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab. 2, 411–420 (2005)
Jordan, S. D., Konner, A. C. & Bruning, J. C. Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell. Mol. Life Sci. 67, 3255–3273 (2010)
Hill, J. W. et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 11, 286–297 (2010)
Lin, H. V. & Accili, D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 14, 9–19 (2011)
DeFronzo, R. A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58, 773–795 (2009)
Edgerton, D. S. et al. Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes 58, 2766–2775 (2009)
Mittelman, S. D., Fu, Y. Y., Rebrin, K., Steil, G. & Bergman, R. N. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J. Clin. Invest. 100, 3121–3130 (1997)
Lu, M. et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nature Med. 18, 388–395 (2012)Systemic insulin administration was shown to suppress HGP effectively in mice with livers that were genetically modified to be unable to respond to the direct effect of insulin, thus establishing the existence of an indirect mechanism for control of HGP.
Cheng, Z. & White, M. F. The AKTion in non-canonical insulin signaling. Nature Med. 18, 351–353 (2012)
Ramnanan, C. J. et al. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J. Clin. Invest. 121, 3713–3723 (2011)
Kishore, P. et al. Activation of KATP channels suppresses glucose production in humans. J. Clin. Invest. 121, 4916–4920 (2011)
Michael, M. D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87–97 (2000)
German, J. P. et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152, 394–404 (2011)Hyperglycaemia was normalized by direct infusion of leptin into the brain of rats with uncontrolled, insulin-deficient diabetes, establishing the inherent capacity of the brain to maintain glucose homeostasis without the need for insulin.
Morton, G. J. & Schwartz, M. W. Leptin and the central nervous system control of glucose metabolism. Physiol. Rev. 91, 389–411 (2011)
Yu, X., Park, B. H., Wang, M. Y., Wang, Z. V. & Unger, R. H. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc. Natl Acad. Sci. USA 105, 14070–14075 (2008)
Kruger, A. J. et al. Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats. Autoimmunity 44, 137–148 (2011)
Havel, P. J. et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am. J. Physiol. 274, R1482–R1491 (1998)
Semple, R. K., Savage, D. B., Cochran, E. K., Gorden, P. & O’Rahilly, S. Genetic syndromes of severe insulin resistance. Endocr. Rev. 32, 498–514 (2011)
German, J. P. et al. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes 59, 1626–1634 (2010)
Schaap, F. G. Role of fibroblast growth factor 19 in the control of glucose homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 15, 386–391 (2012)
Ryan, K. K. et al. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology 154, 9–15 (2013)
Best, J. D. et al. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19, 1018–1030 (1996)A definitive review of glucose effectiveness and its role in both normal glucose homeostasis and diabetes.
Martin, B. C. et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340, 925–929 (1992)
Moore, M. C., Coate, K. C., Winnick, J. J., An, Z. & Cherrington, A. D. Regulation of hepatic glucose uptake and storage in vivo. Adv. Nutr. 3, 286–294 (2012)
D’Alessio, D. A., Kahn, S. E., Leusner, C. R. & Ensinck, J. W. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J. Clin. Invest. 93, 2263–2266 (1994)
Sandoval, D. A., Bagnol, D., Woods, S. C., D’Alessio, D. A. & Seeley, R. J. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57, 2046–2054 (2008)
Kahn, S. E. et al. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J. Clin. Endocrinol. Metab. 71, 994–1002 (1990)
Petersen, K. F. et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 109, 1345–1350 (2002)
Osundiji, M. A. & Evans, M. L. Brain control of insulin and glucagon secretion. Endocrinol. Metab. Clin. North Am. 42, 1–14 (2013)
Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012)
Cai, D. One step from prediabetes to diabetes: hypothalamic inflammation? Endocrinology 153, 1010–1013 (2012)
Posey, K. A. et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296, E1003–E1012 (2009)
Milanski, M. et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61, 1455–1462 (2012)
Horvath, T. L. et al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc. Natl Acad. Sci. USA 107, 14875–14880 (2010)
Alkemade, A. et al. AgRP and NPY expression in the human hypothalamic infundibular nucleus correlate with body mass index, whereas changes in αMSH are related to type 2 diabetes. J. Clin. Endocrinol. Metab. 97, E925–E933 (2012)
Troy, S. et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 8, 201–211 (2008)
Shin, A. C., Zheng, H. & Berthoud, H. R. Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism. Ann. Surg. 255, 294–301 (2012)
Paranjape, S. A. et al. Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated by hypothalamic insulin action. Diabetologia 56, 2055–2058 (2013)
Gerhard, G. S. et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care 36, 1859–1864 (2013)
Ai-Luen, W. et al. Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1. Sci. Transl. Med. 3, 113ra26 (2011)
Acknowledgements
The authors would like to thank A. G. Bell for inspiration and D. Porte Jr for comments. This work was partly funded by National Institutes of Health (NIH) grants DK083042 (M.W.S.), DK093848 (R.J.S.) and DK089053 (G.J.M.), and the Nutrition Obesity Research Centre and Diabetes Research Centre at the University of Washington, and the Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases), through the Initiative and Networking Fund of the Helmholtz Association.
Author information
Authors and Affiliations
Contributions
All of the authors contributed to the ideas presented in and the writing of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schwartz, M., Seeley, R., Tschöp, M. et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 503, 59–66 (2013). https://doi.org/10.1038/nature12709
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12709
This article is cited by
-
Noteworthy perspectives on microglia in neuropsychiatric disorders
Journal of Neuroinflammation (2023)
-
RELA governs a network of islet-specific metabolic genes necessary for beta cell function
Diabetologia (2023)
-
The ventromedial hypothalamic nucleus: watchdog of whole-body glucose homeostasis
Cell & Bioscience (2022)
-
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis
Diabetologia (2022)
-
Seasonal changes in problem-solving in wild African striped mice
Animal Cognition (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.